- Home
- XERS vs MD Comparison
XERS vs MD Comparison
Compare XERS & MD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XERS
- MD
- Stock Information
- Founded
- XERS 2005
- MD 1979
- Country
- XERS United States
- MD United States
- Employees
- XERS N/A
- MD N/A
- Industry
- XERS Biotechnology: Pharmaceutical Preparations
- MD Hospital/Nursing Management
- Sector
- XERS Health Care
- MD Health Care
- Exchange
- XERS Nasdaq
- MD Nasdaq
- Market Cap
- XERS 1.3B
- MD 1.4B
- IPO Year
- XERS 2018
- MD 1995
- Fundamental
- Price
- XERS $9.25
- MD $16.50
- Analyst Decision
- XERS Strong Buy
- MD Buy
- Analyst Count
- XERS 7
- MD 7
- Target Price
- XERS $8.00
- MD $16.79
- AVG Volume (30 Days)
- XERS 2.2M
- MD 693.8K
- Earning Date
- XERS 11-07-2025
- MD 11-05-2025
- Dividend Yield
- XERS N/A
- MD N/A
- EPS Growth
- XERS N/A
- MD N/A
- EPS
- XERS N/A
- MD 1.29
- Revenue
- XERS $246,025,000.00
- MD $1,940,725,000.00
- Revenue This Year
- XERS $43.89
- MD N/A
- Revenue Next Year
- XERS $20.40
- MD $2.68
- P/E Ratio
- XERS N/A
- MD $12.71
- Revenue Growth
- XERS 35.62
- MD N/A
- 52 Week Low
- XERS $2.82
- MD $11.84
- 52 Week High
- XERS $9.41
- MD $18.22
- Technical
- Relative Strength Index (RSI)
- XERS 69.43
- MD 49.71
- Support Level
- XERS $7.78
- MD $15.82
- Resistance Level
- XERS $8.46
- MD $18.22
- Average True Range (ATR)
- XERS 0.41
- MD 0.55
- MACD
- XERS 0.09
- MD -0.10
- Stochastic Oscillator
- XERS 90.32
- MD 30.72
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About MD Pediatrix Medical Group Inc.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.